Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamón, Puerto Rico.
ABSTRACT This article describes and compares distributions of drug-scene roles, frequency of engaging in role behaviors, and relationships of role-holding to high-risk behaviors and sexual partnerships among Puerto Rican injection drug users in New York and Puerto Rico. For this study 561 street-recruited injection drug users in East Harlem, New York, and 312 in Bayamón, Puerto Rico were asked the number of days (in the last 30) in which they earned money or drugs in each of seven drug-scene roles; and about behaviors and egocentric risk partner characteristics in the last 30 days. East Harlem subjects were more likely to get resources by selling drugs and syringes, and buying drugs for someone else; Bayamón subjects were more likely to be "hit doctors," buy needles for others, operate a shooting gallery, or escort others to shooting galleries. All roles were part-time except shooting gallery management in East Harlem. About 27% of respondents at each site engaged in two or more roles. Many roles were associated with increased odds of injecting more than twice a day, receptive syringe sharing, distributive syringe sharing, receptive paraphernalia sharing, and having a drug-injecting sex partner. Drug-scene role structures vary between cities. Most roles are part-time pursuits. Role-holders have higher-risk behaviors and sexual partnerships than other drug injectors. Although further research is needed, drug-scene role-holders should be targeted for interventions to affect their own risk and their communications with others.
SourceAvailable from: Tyson Volkmann[Show abstract] [Hide abstract]
ABSTRACT: Although rates of methamphetamine use continue to increase throughout the United States, little is known about the individuals who sell methamphetamine at the street level. This exploratory study examined the prevalence and correlates of drug-dealing behavior in a sample of 404 heterosexually identified methamphetamine users who were participants in a sexual risk reduction intervention in San Diego, California. Twenty-nine percent of participants (N = 116) reported "dealing" methamphetamine in the past 2 months. In a multivariate logistic regression, methamphetamine dealing was associated with being male (OR = 1.99; 95% CI 1.16-3.39), younger age (OR = 1.87 per year; 95% CI 1.10-3.17), more frequent use of methamphetamine (OR = 2.69; 95% CI 1.59-4.57), injecting methamphetamine (OR = 3.10; 95% CI 1.79-5.37), and higher hostility scores (OR = 1.07 per unit increase; 95% CI 1.01-1.13). These characteristics, particularly intensity of drug use and hostility, may be associated with greater resistance to drug treatment and lower success in treatment programs.American Journal on Addictions 11/2011; 20(6):516-24. DOI:10.1111/j.1521-0391.2011.00173.x · 1.74 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: A large body of research has highlighted practices and rituals that characterise injecting drug use and behavioural and environmental risks that can contribute to the transmission of blood-borne viruses. Compared with other injecting practices, considerably less is known about peer injecting, i.e. receiving or giving injections, particularly the social context in which it occurs. In this article, we explore peer injecting and injecting order at initiation into injecting drug user (IDU) and during subsequent injection episodes. Using data from semi-structured interviews, we highlight the experiences of 41 males and females who had received injections from other IDUs. Respondents were recruited through various strategies, largely chain referral. The results suggest gendered similarities as well as differences in terms of peer injecting, the order of injection and micro-risk contexts for blood-borne viruses.Journal of Substance Use 02/2013; 18(1):31-45. DOI:10.3109/14659891.2012.716901 · 0.48 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Psychopharmacological approaches to drug use focus on psychological traits of drug users and chemical traits of drugs. Whether through medicalisation or demonisation, this defines users as the problem, which ignores socioeconomic and other issues that make individuals, neighbourhoods, and population groups vulnerable to harmful drug use. We discuss a concept of ‘sociopharmacology of drug use’ that locates drug use in broader contexts. This discussion suggests that (a) data on drug-related harm point to the ills and contradictions of society. (b) If anything is to be demonised, a sociopharmacological view suggests that it be the social order, not the individual user. (c) Nonetheless, current drug use patterns cause a lot of misery to drug users, their families, and their neighbours. Research and programs are needed to reduce these harms. (d) Laws that punish users and dealers are at best based on misdiagnosis of the roots of the problem, and can serve to scapegoat the vulnerable. (e) Research should trace how social, economic and health policies create conditions that increase harmful drug use, as well as develop better ways to provide resources to individuals and communities with which to ameliorate conditions that lead to harmful drug use and reduce harmful drug use among drug users. (f) The highest-priority research and action should nonetheless probably focus on social change rather than on changing drug users.International Journal of Drug Policy 11/2002; 13(5):341-347. DOI:10.1016/S0955-3959(02)00082-8 · 2.40 Impact Factor